A research study to see how much CagriSema lowers blood sugar and body weight compared to placebo in people with type 2 diabetes treated with once-daily basal insulin with or without metformin (REIMAGINE 3)
Dose increases typically occur after 48 weeks based on injection site tolerance and biomarker response, guided by provider assessment
Asadzadeh, A., Fassihi, A., Yaghmaei, P
Hartman, MD, a board-certified dermatologist based in Birmingham, Alabama David Kim, MD, a board-certified dermatologist based in New York City Shari Sperling, MD, a board-certified dermatologist based in New York City Mona Gohara, MD, a board-certified dermatologist based in Connecticut How we test and review products When Allure tests a product, our editors look at it from every angle in an effort to best serve you